Myriad Genetics's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
Myriad Genetics last closed at $4.20 (-1.87%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -3.5×. Its overall grade ranks 441 of 738 stocks in Healthcare.
About this company
Myriad Genetics last closed at $4.20 (-1.87%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 441/738
Valuation grade A+
Related stocks
- Thermo Fisher ScientificSupplier
유전자검사·분자진단 장비/시약 공급망 핵심 기업
- IlluminaSupplier
NGS(차세대염기서열분석) 플랫폼·시퀀싱 장비 핵심 공급사
- RocheCompetitor
분자진단·동반진단 및 유전자검사 시장의 글로벌 경쟁사
About Myriad Genetics
- What technical signals does Myriad Genetics (MYGN) have?
- Myriad Genetics current technical signals: no active technical signal.
- Is Myriad Genetics a cup-and-handle pattern?
- No. Myriad Genetics has no valid Cup signal right now.
- What published figures are available for Myriad Genetics?
- Market cap: $391.5M. Trailing 12 months PER: -3.5×. Latest quarter PBR: 1.31×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Myriad Genetics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.